Rayner Intraocular Lenses
Private Company
Funding information not available
Overview
Rayner is a long-established, privately-held leader in the ophthalmic medical device sector, with over 75 years of experience in designing and manufacturing intraocular lenses. The company's core business revolves around its portfolio of IOLs, including the recently FDA-approved RayOne EMV family, and supporting digital platforms like RayPRO for patient-reported outcomes. With a strong heritage, a 'Made in the UK' manufacturing base, and a strategic focus on integrated surgical solutions and digital tools, Rayner is positioned to capitalize on the growing global demand for cataract and refractive surgery.
Technology Platform
Proprietary intraocular lens designs and materials (e.g., RayOne EMV platform) combined with digital health platforms for patient-reported outcomes (RayPRO) and surgical training (Eye Science).
Opportunities
Risk Factors
Competitive Landscape
Rayner competes in the global IOL market against large, diversified multinationals such as Alcon (Novartis spin-off), Johnson & Johnson Vision, and Bausch + Lomb, as well as other specialized players like Carl Zeiss Meditec and Hoya Surgical Optics. Competition is based on lens technology, optical performance, surgeon training, and price.